Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bartoli

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
The Thoracic and Cardiovascular Surgeon|July 5, 2014
Hematologic markers better predict left ventricular assist device thrombosis than echocardiographic or pump parametersCarlo R Bartoli, Amaninderapal S Ghotra, Ajay R Pachika, et al.
The Journal of Invasive Cardiology|March 8, 2013
Percutaneous closure of a patent foramen ovale to prevent paradoxical thromboembolism in a patient with a continuous-flow LVADCarlo R Bartoli, Kelly C McCants, Emma J Birks, et al.
Artificial Organs|May 18, 2012
Counterpulsation with symphony prevents retrograde carotid, aortic, and coronary flows observed with intra-aortic balloon pump supportGuruprasad A Giridharan, Carlo R Bartoli, Paul A Spence, et al.
The Annals of Thoracic Surgery|October 9, 2016
Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist SystemCarlo R Bartoli, Jooeun Kang, David Zhang, et al.
JACC. Basic to Translational Science|March 29, 2021
Abnormalities in the Von Willebrand-Angiopoietin Axis Contribute to Dysregulated Angiogenesis and Angiodysplasia in Children With a Glenn CirculationCarlo R Bartoli, Samson Hennessy-Strahs, Robert D Dowling, et al.
Journal of Cardiovascular Electrophysiology|May 16, 2008
Effect of ranolazine on ventricular vulnerability and defibrillation threshold in the intact porcine heartKapil Kumar, Bruce D Nearing, Carlo R Bartoli, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 2, 2022
Patient-specific severity of von Willebrand factor degradation identifies patients with a left ventricular assist device at high risk for bleedingSamson Hennessy-Strahs, Jooeun Kang, Eric Krause, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2013
Nonphysiologic blood flow triggers endothelial and arterial remodeling in vivo: implications for novel left ventricular assist devices with a peripheral anastomosisCarlo R Bartoli, Paul A Spence, Thorsten Siess, et al.
Journal of Biomedicine & Biotechnology|January 22, 2011
Bovine model of doxorubicin-induced cardiomyopathyCarlo R Bartoli, Kenneth R Brittian, Guruprasad A Giridharan, et al.
JACC. Heart Failure|October 12, 2015
Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated BleedingCarlo R Bartoli, Jooeun Kang, David J Restle, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
The Thoracic and Cardiovascular Surgeon|July 5, 2014
Hematologic markers better predict left ventricular assist device thrombosis than echocardiographic or pump parametersCarlo R Bartoli, Amaninderapal S Ghotra, Ajay R Pachika, et al.
The Journal of Invasive Cardiology|March 8, 2013
Percutaneous closure of a patent foramen ovale to prevent paradoxical thromboembolism in a patient with a continuous-flow LVADCarlo R Bartoli, Kelly C McCants, Emma J Birks, et al.
Artificial Organs|May 18, 2012
Counterpulsation with symphony prevents retrograde carotid, aortic, and coronary flows observed with intra-aortic balloon pump supportGuruprasad A Giridharan, Carlo R Bartoli, Paul A Spence, et al.
The Annals of Thoracic Surgery|October 9, 2016
Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist SystemCarlo R Bartoli, Jooeun Kang, David Zhang, et al.
JACC. Basic to Translational Science|March 29, 2021
Abnormalities in the Von Willebrand-Angiopoietin Axis Contribute to Dysregulated Angiogenesis and Angiodysplasia in Children With a Glenn CirculationCarlo R Bartoli, Samson Hennessy-Strahs, Robert D Dowling, et al.
Journal of Cardiovascular Electrophysiology|May 16, 2008
Effect of ranolazine on ventricular vulnerability and defibrillation threshold in the intact porcine heartKapil Kumar, Bruce D Nearing, Carlo R Bartoli, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 2, 2022
Patient-specific severity of von Willebrand factor degradation identifies patients with a left ventricular assist device at high risk for bleedingSamson Hennessy-Strahs, Jooeun Kang, Eric Krause, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2013
Nonphysiologic blood flow triggers endothelial and arterial remodeling in vivo: implications for novel left ventricular assist devices with a peripheral anastomosisCarlo R Bartoli, Paul A Spence, Thorsten Siess, et al.
Journal of Biomedicine & Biotechnology|January 22, 2011
Bovine model of doxorubicin-induced cardiomyopathyCarlo R Bartoli, Kenneth R Brittian, Guruprasad A Giridharan, et al.
JACC. Heart Failure|October 12, 2015
Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated BleedingCarlo R Bartoli, Jooeun Kang, David J Restle, et al.
Pageof 8